目的:通过对鬼臼毒素母核进行结构改造,以获得高效、低毒、抗多药耐药的新型鬼臼毒素衍生物。方法:将4β-氨基-4-脱氧表鬼臼毒素的C-4位经酰胺化分别引入对位取代的苯甲酸和对位取代的肉桂酸化合物,得到4-甲酰基苯甲酸及4-甲酰基肉桂酸的鬼臼毒素类衍生物,通过MTT法筛选,并对K562和Hela细胞进行药理活性评价。结果:合成得到两个系列共8个化合物,所有化合物都经过HR-ESI-MS和1HNMR验证,其中化合物1d、2b具有较强的体外抗肿瘤活性。结论:在C-4位引入4-甲酰基苯甲酸以及4-甲酰基肉桂酸基团可增加鬼臼毒素类衍生物的抗肿瘤活性。
Objective:To obtain novel podophyllotoxin derivatives with higher efficiency, lower toxicity and anti-multi-drug resistance. Methods:Derivatives of 4-formyl benzoicacid and 4-formyl-cinnamic acid in C-4 position of 4β-amino-pipodophyllotoxin were introduced;Hela cells and K562 were used to evaluate pharmacological activity in vitro. Results:Eight compounds by different methods were obtained, and all compounds were confirmed by MS and 1HNMR validation. The compounds 1b,1d,2a and 2b had a good drug resistance in both Hela and K562 cell line. Conclusion:At C-4 position, podophyllotoxin introduced 4-formyl-benzoyl derivatives and 4-formyl-cinnamic acid derivatives can increase antitumor activities.